AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$7.49
-$0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM ET
$7.49
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:23 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -62.55M |
Depreciation & Amortization | 219K |
Stock-Based Compensation | 5.36M |
Other Working Capital | 406K |
Other Non-Cash Items | 4.83M |
Deferred Income Tax | n/a |
Change in Working Capital | 406K |
Operating Cash Flow | -51.74M |
Capital Expenditures | -4K |
Cash Acquisitions | -3M |
Purchase of Investments | -30M |
Sales Maturities Of Investments | n/a |
Other Investing Acitivies | n/a |
Investing Cash Flow | -33M |
Debt Repayment | -338K |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | n/a |
Financial Cash Flow | -338K |
Net Cash Flow | -85.04M |
Free Cash Flow | -51.75M |
Adj. Free Cash Flow | -57.1M |
Maintenance CapEx | -4K |
Growth CapEx | n/a |
Owner Earnings | -51.75M |
Add to Watchlist
Select watchlists to add or remove AGMB